March 13, 2019
Tvardi Therapeutics Announces Publication Demonstrating TTI-101 as a Therapeutic Option for Treatment-Resistant Breast Cancers

December 12, 2018
Tvardi Therapeutics names Imran Alibhai Chief Executive Officer

June 03, 2020
KRLD Radio Interview: Some Covid Survivors Face Long-Term Consequences

May 20, 2020
Why Overcoming Covid-19 is Just the First Hurdle of a Much Longer Journey: Irreversible Lung Scarring Possible in Survivors

April 09, 2020
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution

March 13, 2019
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ERpositive breast cancer